Ameritas Investment Partners’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Ameritas Investment Partners’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,058	Closed	-$147K	–	3244
2020 Q1	$147K	Hold	3,058	–	–	0.01%	1064
2019 Q4	$144K	Buy	3,058 +358	+13%	+$15.8K	0.01%	1296
2019 Q3	$64K	Hold	2,700	–	–	﹤0.01%	1743
2019 Q2	$81K	Buy	2,700 +1,149	+74%	+$26.3K	﹤0.01%	1637
2019 Q1	$35K	Buy	1,551 +356	+30%	+$7.65K	﹤0.01%	2086
2018 Q4	$22K	Buy	1,195 +480	+67%	+$7.54K	﹤0.01%	2298
2018 Q3	$13K	Hold	715	–	–	﹤0.01%	2748
2018 Q2	$7K	Hold	715	–	–	﹤0.01%	2909
2018 Q1	$4K	Hold	715	–	–	﹤0.01%	2890
2017 Q4	$6K	Hold	715	–	–	﹤0.01%	2856
2017 Q3	$10K	Hold	715	–	–	﹤0.01%	2795
2017 Q2	$13K	Hold	715	–	–	﹤0.01%	2722
2017 Q1	$15K	Buy	+715	New	+$13.7K	﹤0.01%	2563

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Ameritas Investment Partners's RARX Position: Q2 2020 in Review

Ameritas Investment Partners sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 3,058 shares — an estimated $147K sold.

Ameritas Investment Partners first reported a position in RARX in Q1 2017 and held it in 13 quarters. The position peaked at $147K in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Ameritas Investment Partners reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Ameritas Investment Partners sold 3,058 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $147K.
Ameritas Investment Partners first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2017 and held it in 13 quarters.
Ameritas Investment Partners's Ra Pharmaceuticals, Inc. Common Stock position peaked at $147K in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Ameritas Investment Partners's 13F filing for Q2 2020, filed 5 Aug 2020.